Science Access is pleased to welcomes you all for “World cancer conference 2018” which is going to be held from March 19th to 21st at Valencia, Spain. The theme of the congress is “Advances & challenges in Newel Drug Delivery Systems”. 
Cancer 2018 will provide an unparalleled prospect to get associated with leading oncologists, doctors, scientists, academicians, specialists & business associates coming from all over the world. As the theme of the conference relates it serves as a global platform to converse concerning the current developments, recent advances, new approaches and future approaches in the field of cancer science & therapy. 
World Cancer Conference 2018   unites the leading experts over the world to explore their research on cancer. Advancements of techniques to Cancer Immunology, Cancer Vaccines, Cancer drugs and health issues are under constant growth over the last decade as person’s healthy smile depends on an oral health. This World congress will provide a distinctive forum to meet eminent personalities and experience inspiring talks in the field of Cancer and there will be a great affiliation of scientists, professors and industrialists during exciting round table discussions, question answer sessions and unique poster presentations which will help in modernization and advancement of Cancer. Book mark your days from March 19th to 21st for 3 days “World cancer conference” at Valencia, Spain.
Cancer Market Statistics 
More than 20 tumour types are being treated with one or more of the 70 new cancer treatments that have been launched in the past five years, with the sustained surge in innovative therapies driving the global oncology market, added the study – titled ‘Global oncology trend report: A review of 2015 and outlook to 2020’. However, as per the study, many of these drugs are not yet available to patients in most countries, and even when registered they may not be reimbursed under public insurance programs.
It is expected to reach $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumour cell specific genes. The global Cancer therapy market is estimated to grow at 17.6% CAGR to reach $52.2billion by 2021.Oncology Cost Growth is expected in the 7.5% to 10.5% Range Annually Through 2020, when Global Oncology Costs Will exceed $150 Billion.
Higher costs will be driven by the wider usage of new products, especially immunotherapies, in developed markets such as the U.S. and the five major European countries. Newer therapies with increased survival benefits will allow for longer patient treatment, resulting in more lines of therapy and treatment of patients who might otherwise not have been appropriate for therapy. Patent expiries and bio similar competition will contribute to lower costs but will be offset by increased prevalence, diagnosis rates and treatment rates.

Target Audience

• Surgeons.
• Nurses.
• Radiologists
• Directors and CEO’S
• Pathologists
• Research Scholars and Students
• Medical Devices Companies
• Cancer Biologist and oncologists
• Cancer Stem Cell Specialists